PerpEquities

Equity · Healthcare

HCA Healthcare (HCA) perpetual futures

HCA perpetual futures on 2 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade HCAUSDT.

HCA Healthcare operates a network of hospitals and outpatient facilities across the US and England, offering medical, surgical, and specialized care.

$513.57+10.3%NYSE closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · BingX (HCA-USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

2/2 live markets
Venues
2
Live markets
2/2
24h volume
$305.1K
Open interest
$98.8K
Best liquidity
$525
MEXC
Tightest spread
+193.4 bps
MEXC
Highest volume
$203.7K
BingX
Settlement mix
USDT · 2/2
Perp/spot vol.
0.00x
Spot volume $1.8B
OI / float
0.00%
Float $71.7B
Spot performance
1D+10.34%
5D+6.32%
1M+19.69%
6M+19.55%
YTD+9.39%
1Y+8.27%

Venue matrix

2 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
BingXTradeHCA-USDTTrading$515.45-21.9% APR
-0.020% every 8h
+195.6 bps$3.1$203.7K$4.8KUSDT-
MEXCTradeHCA/USDTTrading$513.57-21.9% APR
-0.020% every 8h
+193.4 bps$525$101.4K$94KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 2 venues absorb $10k

No fresh book data: MEXC, BingX

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

HCA

Tightest spread

HCA

Highest volume

HCA

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-29 · next report 2027-01-26 · Updated 125h ago
All financials →

Valuation & key figures

Market cap
$102.5B
Updated 125h ago
Revenue
$78.7B
Trailing 12 months
Revenue growth
+5%
Next fiscal year
Profit margin
+8.6%
P/E
57.5
Peer P/E 19.6
P/S
1.3
Peer P/E
19.6
Similar listed perps
Free cash flow
$6B
Trailing 12 months
Net income
$6.8B
Trailing 12 months
Revenue estimate
$79B
Next fiscal year
Earnings
2027-01-26
Revenue est. $20B · Updated 125h ago
Dividend
$0.78
2026-12-15
Revenue (TTM)$78.7B+5.8% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)15.3%-0.3 pp vs a year agoOperating income $12.1B
Net income (TTM)$6.78B+6.8% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$5.97B-26.2% vs a year agoCapex $5.2B
Diluted EPS (TTM)$30.18+16.7% vs a year agoSum of the last 4 quarters
Net cash-$51.5B-13.6% vs a year agoCash + short-term investments - debt
  • Last report (2026-10-27): revenue beat by 2.7%, EPS beat by 8.6%Revenue $19.8B vs $19.3B expected (+2.7%); EPS $7.22 vs $6.65 (+8.6%).
  • Revenue growth slowing: 3.6% year on yearQ3 '26 revenue $19.8B, against an average of 7.3% over the four quarters before.
  • Operating margin 15.3% (TTM), -0.3 pp on a year agoOperating income grew 3.8% while revenue grew 5.8%.
  • 22.9% of pre-tax profit is eaten by non-operating lossesPre-tax income $9.82B vs operating income $12.1B (TTM). Losses on equity stakes and other one-off items cut net income and EPS - operating income is the cleaner measure of the business.

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Managed Care And Other Insurers$9.57B+3.3%49.7%
Managed Medicare$3.53B+6.8%18.3%
Medicare$2.93B+7.2%15.2%
Medicaid$1.77B-1.0%9.2%
Managed Medicaid$961M+1.3%5.0%
International$492M+1.7%2.6%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 237 lines HCA Healthcare, Inc. reported to the SEC

Next catalyst

Catalysts

Earnings
2027-01-26
Revenue est. $20B · Updated 125h ago
Dividend
$0.78
2026-12-15

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202629.98$79B+5%14
FY 202731.48$81.6B+8%16
FY 202835.10$85.3B+13%12
FY 202939.12$90.9B+20%9
FY 203044.62$96.3B+27%5
Q1 20277.55$19.9B+4%9

Company events

6
2027-01-26EarningsActual - / Estimate 8.16-
2026-12-15Dividend$0.78-
2026-10-27Earnings · Before market openActual 7.22 / Estimate 6.65Beat
2026-09-16Dividend$0.78-
2026-07-24EarningsActual 7.59 / Estimate 7.56Beat
2026-06-16Dividend$0.78-

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 2, 2026, 03:10 PM UTC

Company profile

Sector
Healthcare
Industry
Medical - Care Facilities
Chief executive
Samuel N. Hazen
Employees
320,000
IPO date
Mar 10, 2011
Country
US
Exchange
New York Stock Exchange
Website
Altman Z-scorei2.51
Piotroski scorei6/9
Overall ratingiC+
Owner earningsi$3.42B$15.73 per share
ESG risk ratingiBIndustry rank: 64 out of 78

Rating factors

Return on equityi
1
Return on assetsi
5
Debt to equityi
1
Price to earningsi
1
Price to booki
1
Market cap history
$105.14B+16.0%Aug 26 – Oct 26
$89.58B$97.36B$105.14BLow: $89.58B · 2026-09-08Latest: $105.14B · 2026-10-30Aug 26Sep 26Oct 26
Latest: $105.14B · 2026-10-30High: $105.14B · 2026-10-30Low: $89.58B · 2026-09-08
Largest fund holders
FundWeightShares held
VCPA.S0.45%20.9M
VSCA.S0.34%10.2M
VTI0.08%4.5M
VOO0.1%3.9M
FLUD0.31%2M
IVV0.11%2M
XSP.TO0.1%2M
SPY0.11%1.8M
FXAIX0.1%1.7M
VWNAX0.95%1.5M
VGHAX1.62%1.5M
VTV0.23%1.3M

Analyst track record

How the analysts covering HCA have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings127364
Analysts2737
Buy / hold / sell74 / 48 / 5245 / 110 / 9
Upgrades / downgrades / initiations0 / 2 / 11 / 10 / 7
Price targets hit / missed50 / 68 (42%)247 / 80 (76%)
Avg. return after a rating (TipRanks)+0.7%+17.0%
Best / worst call+29.6% / -24.7%+80.4% / -24.7%

After buy calls on this stock: median 21-day move +6.3% vs S&P 500 +2.7% (n = 260)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Andrew Mok CFABarclays100% hit rate on this stock · 18 targets measuredHoldtarget $401Oct 29, 2026
  2. Ben HendrixRBC Capital100% hit rate on this stock · 15 targets measuredBuytarget $521Oct 29, 2026
  3. Sarah JamesCantor Fitzgerald100% hit rate on this stock · 14 targets measuredBuytarget $525Jul 14, 2026

Latest ratings

DateAnalystCallTarget
Nov 2, 2026Stephen BaxterWells FargoHoldMaintained$468
Oct 29, 2026Ben HendrixRBC CapitalBuyMaintained$521
Oct 29, 2026Andrew Mok CFABarclaysHoldMaintained$401
Oct 29, 2026Andrew Mok CFABarclaysHoldMaintained$401
Oct 28, 2026Ryan LangstonTD CowenBuyMaintained$486
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$380$400$420$440$460$480$500$520$540Dec 25 · Buy 14 · Hold 10 · Sell 0Dec 25Jan 26 · Buy 14 · Hold 7 · Sell 1Feb 26 · Buy 14 · Hold 6 · Sell 1Feb 26Mar 26 · Buy 14 · Hold 6 · Sell 1Apr 26 · Buy 12 · Hold 6 · Sell 1Apr 26May 26 · Buy 12 · Hold 6 · Sell 1Jun 26 · Buy 13 · Hold 6 · Sell 1Jun 26Jul 26 · Buy 13 · Hold 7 · Sell 1Aug 26 · Buy 14 · Hold 7 · Sell 1Aug 26Sep 26 · Buy 16 · Hold 7 · Sell 1Oct 26 · Buy 15 · Hold 7 · Sell 1Oct 26Nov 26 · Buy 15 · Hold 7 · Sell 1Dec 25 · avg. target $477Jan 26 · avg. target $513Feb 26 · avg. target $533Mar 26 · avg. target $534Apr 26 · avg. target $523May 26 · avg. target $519Jun 26 · avg. target $509Jul 26 · avg. target $459Aug 26 · avg. target $459Sep 26 · avg. target $461Oct 26 · avg. target $470Nov 26 · avg. target $470Dec 25 · month-end close $467Jan 26 · month-end close $488Feb 26 · month-end close $530Mar 26 · month-end close $473Apr 26 · month-end close $434May 26 · month-end close $379Jun 26 · month-end close $390Jul 26 · month-end close $403Aug 26 · month-end close $414Sep 26 · month-end close $427Oct 26 · month-end close $473Nov 26 · month-end close $473

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 2, 2026 · 127 ratings

Frequently asked questions

Where can I trade HCA perpetual futures?

HCA Healthcare (HCA) perpetual futures trade on 2 crypto venues, including BingX, MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade HCA around the clock?

Yes. Unlike the underlying stock, HCA perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on HCA perpetuals?

Right now the HCA perp funding rate is -21.9% annualized (venue median), ranging from -21.9% to -21.9% across 2 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the HCA perp price compare to the HCA Healthcare stock?

The venue-median HCA perp mark is $514.5 versus a reference stock price of $513.6, a basis of +0.2%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a HCA perpetual future?

A HCA perpetual is a derivative that tracks the price of HCA Healthcare with no expiry date. It lets you take long or short exposure to HCA Healthcare on crypto venues, around the clock.

What is HCAUSDT perpetual?

HCAUSDT is the symbol most crypto exchanges use for the HCA Healthcare perpetual settled in USDT (Tether). It tracks the HCA share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

HCA perpetuals · perpequities.comHCA perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/hca-perp"><img src="https://perpequities.com/badge/hca-perp.svg" width="240" height="64" alt="HCA perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of HCA perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for HCA — one email every Sunday.

Watchlist and alerts

Price and funding alerts for HCA, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X